Decreased Facilitation by Angiotensin II of Noradrenergic Neurotransmission in Isolated Mesenteric Artery of Rabbits with Chronic Heart Failure
- 1 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 41 (3) , 356-362
- https://doi.org/10.1097/00005344-200303000-00003
Abstract
Both in human and in experimental heart failure (HF), the renin-angiotensin system and the sympathetic nervous system are activated. In a previous study a facilitatory action of angiotensin II (Ang II) was shown in the rabbit mesenteric artery, which was mediated via prejunctionally located Ang II type 1 (AT1) receptors. Very little is known about the effects of Ang II on sympathetic neurotransmission at the peripheral level in congestive heart failure (CFH). Accordingly, in the isolated mesenteric arteries obtained from rabbits with experimentally induced CHF, as well as in age-matched control rabbits, the effect of Ang II on contractions provoked by electrical field stimulation was investigated in the presence and absence of the AT1 receptor antagonist eprosartan. Additionally, to investigate a possible postjunctional facilitation, the effects of Ang II on α-adrenoceptor-mediated responses were studied using noradrenaline (NA). Lastly, the vasoconstrictor effects of Ang II were compared between HF rabbits and controls, by constructing concentration-response curves to Ang II. In control rabbits, Ang II 0.5 n M caused an enhancement of stimulation-induced responses by a factor 3.2 ± 0.5, 2.4 ± 0.3, and 1.5 ± 0.08, at 1, 2, and 4 Hz, respectively (P MKeywords
This publication has 32 references indexed in Scilit:
- Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudyEuropean Journal of Heart Failure, 1999
- Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in ratsCardiovascular Research, 1999
- Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular DysfunctionCirculation, 1996
- Losartan in Heart FailureCirculation, 1995
- Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.Circulation, 1993
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Sympathetic activation in congestive heart failureEuropean Heart Journal, 1990
- Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentrationAmerican Heart Journal, 1987
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985